More on the toxicity of decabromodiphenyl ether-Response to Hardy et al. (2008)

Toxicology Letters

Volumn 182, Issue 1-3, 2008, Pages 130-132

  van der Ven, Leo T M ^a   Slob, Wout ^a,b   Piersma, Aldert H ^a   Leonards, Pim E G ^c   Hamers, Timo ^c   Sandholm, Anna ^d   Van den Berg, Martin ^b   Opperhuizen, Antoon ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c INSTITUTE FOR ENVIRONMENTAL STUDIES   (Netherlands)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2B; DECABROMODIPHENYL ETHER; DIPHENYL ETHER DERIVATIVE; MESSENGER RNA; UNCLASSIFIED DRUG;

BIOAVAILABILITY; COMPUTER PROGRAM; DOSE RESPONSE; INFORMATION PROCESSING; LETTER; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SEMINAL VESICLE; VALIDITY;

EID: 55049085026     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.09.005     Document Type: Letter

References (12)

1. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Kester M.H.A., Andersson P.L., Legler J., and Brouwer A. In vitro profiling of the endocrine disrupting potency of brominated flame retardants. Toxicol. Sci. 92 (2006) 157-173
2. Hansen, B.G., Munn, S.J., De Bruijn, J., Luotamo, M., Pakalin, S., Berthault, F., Vegro, S., Pellegrini, G., Allanou, R., Scheer, S., 2002. European Union Risk Assessment Report-bis(pentabromophenyl) ether. Office for Official Publications of the European Communities, Luxembourg.
3. Hardy M.L., Schroeder R., Biesemeier J., and Manor O. Prenatal oral (gavage) developmental toxicity study of decabromodiphenyl oxide in rats. Int. J. Toxicol. 21 (2002) 83-91
4. Hardy M.L., Ranken P., Hsu C.-H., Stedeford T., Van der Ven L.T.M., et al. Deriving risks based on model parameters rather than experimental data. Toxicol. Lett. 182 (2008) 127-129
5. Huwe J.K., and Smith D.J. Accumulation, whole-body depletion, and debromination of decabromodiphenyl ether in male Sprague-Dawley rats following dietary exposure. Environ. Sci. Technol. 41 (2007) 2371-2377
6. Korytar P., Covaci A., Leonards P.E., De Boer J., and Brinkman U.A. Comprehensive two-dimensional gas chromatography of polybrominated diphenyl ethers. J. Chromatogr. A 1100 (2005) 200-207
7. Mörck A., Hakk H., Orn U., and Klasson W.E. Decabromodiphenyl ether in the rat: absorption, distribution, metabolism, and excretion. Drug Metab. Dispos. 31 (2003) 900-907
8. National Toxicology Program, 1986. Toxicology and carcinogenesis studies of decabromodiphenyl oxide (CAS no. 1163-19-5) in F344/N rats and B6C3F1 mice (feed studies).
9. Norris J.M., Kociba R.J., Schwetz B.A., Rose J.Q., Humiston C.G., Jewett G.L., Gehring P.J., and Mailhes J.B. Toxicology of octabromobiphenyl and decabromodiphenyl oxide. Environ. Health Perspect. 11 (1975) 153-161
10. Ranken P., Freibur M., Mazac C., Bauer M., Varcoe F., and Tondeur Y. Definitive study of the determination of polybrominated dibenzo-p-dioxins and polybrominated dibenzofurans in decabromodiphenyl oxide and tetrabromobisphenol A. Bull. Soc. Chim. Belg. 103 (1994) 219-233 (European Section)
11. Sandholm A., Emanuelsson B.M., and Wehler E.K. Bioavailability and half-life of decabromodiphenyl ether (BDE-209) in rat. Xenobiotica 33 (2003) 1149-1158
12. Van der Ven L.T.M., van de Kuil T., Leonards P.E., Slob W., Cantón R.F., Germer S., Visser T.J., Litens S., Håkansson H., Schrenk D., Van den Berg M., Piersma A.H., Vos J.G., and Opperhuizen A. A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE). Toxicol. Lett. 179 (2008) 6-14